MedPath

Evaluation of a dementia-specific training in patients with mild to moderate-stage dementia

Completed
Conditions
Unspecified dementia
Mild to moderate stage, diagnostically confirmed dementia
Mental and Behavioural Disorders
Registration Number
ISRCTN37232817
Lead Sponsor
Dietmar Hopp Foundation (Germany)
Brief Summary

2018 results in: https://www.ncbi.nlm.nih.gov/pubmed/30409202

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
92
Inclusion Criteria

1. Age >65
2. Mild to moderate stage cognitive impairment (MMSE:17-26)
3. Diagnosis of mild to moderate stage dementia based on established international criteria
4. Written informed consent
5. Consent of legal guardian (if assigned)
6. Ability to walk 10 m without aid
7. Living in the vicinity of the study location (<20 km)

Exclusion Criteria

1. Severe psychical disease (substance abuse, psychosis)
2. Severe somatic disease (e.g. heart failure NYHA >3, uncontrolled Diabetes Mellitus)

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Improvement of dual task performance (trained and non-trained tasks as measured by electronic gait (Gait rite) and strength analysis (Diagnos 40) and specified cognitive tests) and executive function as measured by biomechanical analyses (DynaPort Hybrid and Physiomat training device) after intervention.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath